CORK, IRELAND — FEBRUARY 27, 2008 - QUMAS, the leader in Enterprise Governance, Risk and Compliance (GRC) solutions, today announced that it is exhibiting at the DIA 20th Annual EuroMeeting being held March 3 -5, at the Centre de Convencions Internacional de Barcelona in Barcelona, Spain. QUMAS will be located in booth #160.
The DIA 20th Annual EuroMeeting is global in scope, attracting more than 3,000 industry professionals from over 50 countries. This one-of-a-kind meeting brings together professionals from the biopharmaceutical industry, contract service organizations, academic research centers, and regulatory agencies. With more than 100 sessions and 10 themes, the annual event covers a variety of cross-disciplinary topics—from regulatory to health economics.
For more information, visit http://www.diahome.org.
QUMAS representatives will be in attendance to discuss and demo the QUMAS Quality Management Solution. The QUMAS Quality Management Solution is designed to help companies comply with standard operating procedures, as well as industry standards and regulations, take proactive measures to improve quality operations, and respond in real time to deviations that occur. More than 80 life sciences companies rely on QUMAS to automate their quality and regulatory processes, including seven of the top 10 pharmaceuticals, and four of the top 10 biotechs.
QUMAS is the only vendor that provides a complete compliance and validation record across FDA, ISO, DoD, and other global regulations. In addition QUMAS is one of the few vendors in the compliance industry that is ISO 9001:2000 certified ensuring a structured approach to automating and streamlining content, process and quality management requirements including:
- SOP Management
- Corrective and Preventive Actions
- Customer Complaints
- Change Control
- Policy Training and Certification
From initiation to closure, QUMAS captures, records, routes and verifies completion and approvals while auditing each step in the quality management process. By using a single, integrated solution to address compliance and quality management, life sciences organizations realize reduced operational and training costs, significantly faster response times for regulatory inquiries and changing legislative demands, and avoidance of resource duplication and ongoing validation costs.
QUMAS is the leader in Enterprise Governance, Risk and Compliance (GRC) with more than 250 customer deployments and over a decade of experience helping companies in highly regulated industries provide a proactive regulatory defense.
QUMAS solutions for life sciences are designed to achieve compliance with industry and government standards for 21 CFR Part 11, cGxP, Quality, R&D, Regulatory Affairs and Clinical Operations. QUMAS enables organizations to bring new drugs to market faster with better quality submissions while proactively managing regulated content and controls, reducing costs, and improving customer satisfaction.
For more information visit http://www.qumas.com.
# # #
All trade names, trademarks, and service marks are the rightful property of their respective owners.